Export 63 results:
Filters: Keyword is Disease Models, Animal  [Clear All Filters]
J. McLean, Liu, H. - N., Miletic, D., Weng, Y. Cheng, Rogaeva, E., Zinman, L., Kriz, J., and Robertson, J., Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease., J Neurochem, vol. 114, no. 4, pp. 1177-92, 2010.
S. Takeuchi, Fujiwara, N., Ido, A., Oono, M., Takeuchi, Y., Tateno, M., Suzuki, K., Takahashi, R., Tooyama, I., Taniguchi, N., J-P Julien, and Urushitani, M., Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice., J Neuropathol Exp Neurol, vol. 69, no. 10, pp. 1044-56, 2010.
D. Rylander, Parent, M., O'Sullivan, S. S., Dovero, S., Lees, A. J., Bezard, E., Descarries, L., and M Cenci, A., Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia., Ann Neurol, vol. 68, no. 5, pp. 619-28, 2010.
S. Abou Ezzi, Larivière, R., Urushitani, M., and J-P Julien, Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS., J Neurochem, vol. 115, no. 5, pp. 1102-11, 2010.
F. Dequen, Filali, M., Larivière, R. C., Perrot, R., Hisanaga, S. - I., and J-P Julien, Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E., Hum Mol Genet, vol. 19, no. 13, pp. 2616-29, 2010.
J. - N. Audet, Gowing, G., and J-P Julien, Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R., Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.
F. Gros-Louis, Kriz, J., Kabashi, E., McDearmid, J., Millecamps, S., Urushitani, M., Lin, L., Dion, P., Zhu, Q., Drapeau, P., J-P Julien, and Rouleau, G. A., Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish., Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
D. A. Nita, Cissé, Y., and Timofeev, I., EPSP depression following neocortical seizures in cat., Epilepsia, vol. 49, no. 4, pp. 705-9, 2008.
M. Battaglia, Marino, C., Maziade, M., Molteni, M., and D'Amato, F., Gene-environment interaction and behavioral disorders: a developmental perspective based on endophenotypes., Novartis Found Symp, vol. 293, pp. 31-41; discussion 41-7, 68-70, 2008.
P. Huot, Lévesque, M., Morissette, M., Calon, F., Dridi, M., Di Paolo, T., and Parent, A., L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys., J Chem Neuroanat, vol. 35, no. 1, pp. 77-84, 2008.
F. Dequen, Bomont, P., Gowing, G., Cleveland, D. W., and J-P Julien, Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1., J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
B. Barrette, Hébert, M. - A., Filali, M., Lafortune, K., Vallières, N., Gowing, G., J-P Julien, and Lacroix, S., Requirement of myeloid cells for axon regeneration., J Neurosci, vol. 28, no. 38, pp. 9363-76, 2008.
S. Avramescu and Timofeev, I., Synaptic strength modulation after cortical trauma: a role in epileptogenesis., J Neurosci, vol. 28, no. 27, pp. 6760-72, 2008.

Funding / Support / Partners

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord